Bain Capital Specialty Finance , Inc. (NYSE:BCSF), a specialty finance company with a market capitalization of $1.17 billion and trading near its 52-week high of $18.35, announced the issuance of $350 ...

Hillenbrand Inc. has announced the sale of a 51% stake in its Milacron injection molding and extrusion business to an ...

BRENTWOOD, Tenn. - Surgery Partners, Inc. (NASDAQ: NASDAQ:SGRY), a prominent operator of short-stay surgical facilities with ...

An affiliate of Bain Capital will acquire 51 per cent of the injection molding and extrusion machinery maker from current owner Hillenbrand Inc.

Bain Capital will partner with Milacron’s current owner, Hillenbrand, Inc. (NYSE: HI), who will remain a significant investor in the business to accelerate the Company’s continued growth. Bain Capital ...

Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners it ...

BOSTON--(BUSINESS WIRE)--Bain Capital Specialty Finance, Inc. (NYSE: BCSF or the “Company”) today announced that it has priced an offering of $350 million aggregate principal amount of 5.950% ...

Surgery Partners received a non-binding acquisition proposal from Bain Capital for $25.75 per share, pending Board review. Surgery Partners, Inc. announced that its Board of Directors received a ...

Hillenbrand Inc. has announced the sale of a 51 percent stake in its Milacron injection molding and extrusion machinery ...

Bain Capital Specialty Finance, Inc. today announced that it has priced an offering of $350 million 5.950% senior notes due 2030.